It is important to note that the Food and Drug Administration (FDA) has historically had a bias against cannabis and has been slow to recognize the potential therapeutic benefits of the plant. This is likely due to the longstanding federal prohibition on cannabis, which has made it difficult for researchers to study the plant and for the FDA to regulate it as a medicine.
The incident involving Cost Cannabis in Revelstoke, British Columbia, raises significant questions about pricing strategies…
He emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from…
"How Long Does One Puff of Weed Stay in Your System?"... This topic can be difficult…
GMO x Purple Punch deliver a knockout. The post Sleep through it all with Modified…
As the popularity of CBD (cannabidiol) continues to rise, many pet owners are exploring its…
An intriguing trend has emerged In recent years within the world of professional golf: a…